Related Experiment Video
Updated: Feb 4, 2026

Extraction and Characterization of Surfactants from Atmospheric Aerosols
Published on: April 21, 2017
Surfactant enhanced flow injection chemiluminescence method for vitamin D3 determination in pharmaceutical
Fatima Khan1, Mohammad Yaqoob2, Muhammad Asghar2
1Department of Chemistry, Sardar Bahadur Khan Women's University, Quetta 87300, Pakistan.
Abstract:
A flow injection based chemiluminescence process has been reported for vitamin D3 determination without using especial chemiluminescence reagent. Vitamin D3 shows enhancement on the CL intensity of diperiodatocuprate(III) with surfactant (Triton X-100) solution. The calibration curve was found to be linear over the concentration range 0.01-40 mg/L (R2 = 0.9997, n = 8) tested. A limit of detection (S/N = 3), limit of quantification (S/N = 10) and sample injection throughput of 2.5 × 10-3, 8.3 × 10-3 mg/L and 150 h-1 respectively were obtained. Various experimental variables were tested to get most suitable response, e.g., the concentrations of reagents, and their flow rates, sample injection volume and photomultiplier tube voltage. The effect of potential interferences was also examined. Vitamin D3 determination was successfully carried out in pharmaceutical formulations. The recoveries from the formulations were obtained in the range of 96 ± 4-108 ± 2%. The reaction mechanism discussion for diperiodatocuprate(III) complex-Triton X-100-vitamin D3 was also included.
More Related Videos
Related Concept Videos
Vitamins
Pharmaceutical Equivalents
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Determining Order of Reaction
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

